Actively Recruiting

Age: 16Years - 80Years
All Genders
NCT06730529

The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases

Led by Ruijin Hospital · Updated on 2024-12-12

40

Participants Needed

1

Research Sites

265 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to investigate the value of 68Ga-FAPI in the preoperative evaluation of thyroid cancer of different pathologic types.

CONDITIONS

Official Title

The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases

Who Can Participate

Age: 16Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pathological and clinical diagnosis of thyroid cancer with lymph node metastases.
  • Signed and dated informed consent form.
  • Commitment to comply with research procedures and co-operation in the implementation of the full research process.
  • Aged 16-80 years old.
Not Eligible

You will not qualify if you...

  • Serious illnesses deemed unsuitable by researchers, such as severe heart and lung failure, severe bone marrow suppression, or severe liver and kidney dysfunction.
  • Intestinal perforation or complete intestinal obstruction.
  • Pregnant women, women who may be pregnant, and breastfeeding women.
  • Persons who are non-compliant with study procedures.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine

Shanghai, Shanghai Municipality, China, 200001

Actively Recruiting

Loading map...

Research Team

J

Jiajia Hu

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here